Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused by diabetes (diabetic peripheral neuropathy).
Diabetic Peripheral Neuropathy
Age Range:
18 to 80
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This research study is evaluating an investigational medication for its ability to help reduce nerve pain associated with diabetic peripheral neuropathy.
Diabetic peripheral neuropathy is a common complication of diabetes that can cause symptoms like:
- Burning or shooting pain
- Tingling or numbness
- Sensitivity in the legs or feet
Current treatment options may not work well for everyone or may cause unwanted side effects. This study is exploring a different approach that targets how pain signals are sent through the nerves.
Qualifications
You may be able to participate if you:
- Are 18 to 80 years of age
- Have been diagnosed with type 1 or type 2 diabetes
- Experience moderate nerve pain in both legs or feet for at least 1 year
- Have stable diabetes management
- Are not pregnant or planning to become pregnant
Additional criteria will be reviewed by the study team to determine eligibility.
FEATURED STUDIES
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]